Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Acquisitions & Divestments: 2011-2025

Historic Change in Acquisitions & Divestments for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $262.9 million.

  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments rose 158.27% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.9 million, marking a year-over-year decrease of 31.45%. This contributed to the annual value of $262.9 million for FY2025, which is 31.45% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Change in Acquisitions & Divestments of $262.9 million as of FY2025, which was down 31.45% from $383.5 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Change in Acquisitions & Divestments registered a high of $383.5 million during FY2024, and its lowest value of $228.5 million during FY2022.
  • For the 3-year period, Enanta Pharmaceuticals' Change in Acquisitions & Divestments averaged around $325.1 million, with its median value being $328.9 million (2023).
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 33.79% in 2022, then soared by 43.95% in 2023.
  • Yearly analysis of 5 years shows Enanta Pharmaceuticals' Change in Acquisitions & Divestments stood at $345.1 million in 2021, then slumped by 33.79% to $228.5 million in 2022, then soared by 43.95% to $328.9 million in 2023, then climbed by 16.60% to $383.5 million in 2024, then tumbled by 31.45% to $262.9 million in 2025.